These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
261 related articles for article (PubMed ID: 6323674)
1. Fenfluramine, p-chloroamphetamine and p-fluoroamphetamine stimulation of pituitary-adrenocortical activity in rat: evidence for differences in site and mechanism of action. McElroy JF; Miller JM; Meyer JS J Pharmacol Exp Ther; 1984 Mar; 228(3):593-9. PubMed ID: 6323674 [TBL] [Abstract][Full Text] [Related]
2. Effects of the serotonin releasers 3,4-methylenedioxymethamphetamine (MDMA), 4-chloroamphetamine (PCA) and fenfluramine on acoustic and tactile startle reflexes in rats. Kehne JH; McCloskey TC; Taylor VL; Black CK; Fadayel GM; Schmidt CJ J Pharmacol Exp Ther; 1992 Jan; 260(1):78-89. PubMed ID: 1731054 [TBL] [Abstract][Full Text] [Related]
3. Carrier-dependent and Ca(2+)-dependent 5-HT and dopamine release induced by (+)-amphetamine, 3,4-methylendioxymethamphetamine, p-chloroamphetamine and (+)-fenfluramine. Crespi D; Mennini T; Gobbi M Br J Pharmacol; 1997 Aug; 121(8):1735-43. PubMed ID: 9283711 [TBL] [Abstract][Full Text] [Related]
4. Effect of serotonin-releasing drugs on serum corticosterone concentration in rats. Fuller RW; Snoddy HD Neuroendocrinology; 1980 Aug; 31(2):96-100. PubMed ID: 6446690 [TBL] [Abstract][Full Text] [Related]
5. The substituted amphetamines 3,4-methylenedioxymethamphetamine, methamphetamine, p-chloroamphetamine and fenfluramine induce 5-hydroxytryptamine release via a common mechanism blocked by fluoxetine and cocaine. Berger UV; Gu XF; Azmitia EC Eur J Pharmacol; 1992 May; 215(2-3):153-60. PubMed ID: 1356787 [TBL] [Abstract][Full Text] [Related]
7. Sleep suppressant action of fenfluramine in rats. II. Evidence against the involvement of presynaptic serotonergic mechanism. Fornal C; Radulovacki M J Pharmacol Exp Ther; 1983 Jun; 225(3):675-81. PubMed ID: 6223135 [TBL] [Abstract][Full Text] [Related]
8. Central 5-hydroxytryptamine2 receptors are involved in the adrenal catecholamine-releasing and hyperglycemic effects of the 5-hydroxytryptamine indirect agonist d-fenfluramine in the conscious rat. Chaouloff F; Gunn SH; Young JB J Pharmacol Exp Ther; 1992 Mar; 260(3):1008-16. PubMed ID: 1545373 [TBL] [Abstract][Full Text] [Related]
9. Hemodynamic pharmacology of p-chloroamphetamine, a serotonin agonist, in conscious rats. Alper RH; Lee C; Brody MJ J Pharmacol Exp Ther; 1987 Nov; 243(2):446-54. PubMed ID: 3681694 [TBL] [Abstract][Full Text] [Related]
10. Neurons in the hypothalamic paraventricular nucleus mediate the serotonergic stimulation of prolactin secretion via 5-HT1c/2 receptors. Rittenhouse PA; Levy AD; Li Q; Bethea CL; Van de Kar LD Endocrinology; 1993 Aug; 133(2):661-7. PubMed ID: 8344205 [TBL] [Abstract][Full Text] [Related]
12. Pharmacological studies on the serotoninergic and nonserotonin-mediated stimulation of prolactin and corticosterone secretion by fenfluramine. Effects of pretreatment with fluoxetine, indalpine, PCPA, and L-tryptophan. Van de Kar LD; Urban JH; Richardson KD; Bethea CL Neuroendocrinology; 1985 Oct; 41(4):283-8. PubMed ID: 2931613 [TBL] [Abstract][Full Text] [Related]
13. Differential effects of d-fenfluramine and p-chloroamphetamine on H75/12-induced depletion of 5-hydroxytryptamine and dopamine in the rat brain. Fattaccini CM; Gozlan H; Hamon M Neuropharmacology; 1991 Jan; 30(1):15-23. PubMed ID: 1710793 [TBL] [Abstract][Full Text] [Related]
14. Elevations in plasmatic titers of corticosterone and aldosterone, in the absence of changes in ACTH, testosterone, or glial fibrillary acidic protein, 72 h following D,L-fenfluramine or D-fenfluramine administration to rats. Williams MT; Morford LL; McCrea AE; Inman-Wood SL; Vorhees CV Neurotoxicol Teratol; 2001; 23(1):23-32. PubMed ID: 11274873 [TBL] [Abstract][Full Text] [Related]
15. Evidence for an involvement of peripheral serotonin in p-chloroamphetamine-induced ejaculation of rats. Yonezawa A; Yoshizumi M; Ebiko M; Iwanaga T; Kimura Y; Sakurada S Pharmacol Biochem Behav; 2005 Dec; 82(4):744-50. PubMed ID: 16413602 [TBL] [Abstract][Full Text] [Related]
16. Elevation of serum prolactin and corticosterone concentrations in the rat after the administration of 3,4-methylenedioxymethamphetamine. Nash JF; Meltzer HY; Gudelsky GA J Pharmacol Exp Ther; 1988 Jun; 245(3):873-9. PubMed ID: 2898523 [TBL] [Abstract][Full Text] [Related]
17. Short-term and long-term effects of p-chloroamphetamine on hippocampal serotonin and corticosteroid receptor levels. Novotney S; Lowy MT Brain Res; 1995 Jun; 684(1):19-25. PubMed ID: 7583200 [TBL] [Abstract][Full Text] [Related]
18. In vivo correlates of central serotonin function after high-dose fenfluramine administration. Baumann MH; Ayestas MA; Rothman RB Ann N Y Acad Sci; 1998 May; 844():138-52. PubMed ID: 9668672 [TBL] [Abstract][Full Text] [Related]
19. Serotonin-lesion myoclonic syndromes. II. Analysis of individual syndrome elements, locomotor activity and behavioral correlations. Pranzatelli MR; Snodgrass SR Brain Res; 1986 Jan; 364(1):67-76. PubMed ID: 3484993 [TBL] [Abstract][Full Text] [Related]
20. Forebrain serotonin and avoidance learning: behavioural and biochemical studies on the acute effect of p-chloroamphetamine on one-way active avoidance learning in the male rat. Ogren SO Pharmacol Biochem Behav; 1982 Jun; 16(6):881-95. PubMed ID: 7111347 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]